Nicolaas I. Bohnen

Overview

Best Publications

• Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

  Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  4225
  Citations

• Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.

  Keith A. Johnson;Satoshi Minoshima;Nicolaas I. Bohnen;Kevin J. Donohoe

  1459
  Citations

• Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.

  Nicolaas I. Bohnen;Daniel I. Kaufer;Larry S. Ivanco;Brian Lopresti

  666
  Citations

• The Cholinergic System and Parkinson Disease

  Nicolaas I. Bohnen;Roger L. Albin

  651
  Citations

• Subtraction ictal SPECT co‐registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus

  Unknown

  534
  Citations

• History of falls in Parkinson disease is associated with reduced cholinergic activity

  N. I. Bohnen;M. L.T.M. Müller;R. A. Koeppe;S. A. Studenski

  449
  Citations

• Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia

  Nicolaas I. Bohnen;Daniel I. Kaufer;Rick Hendrickson;Larry S. Ivanco

  448
  Citations

• Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.

  Nicolaas I. Bohnen;Martijn L. T. M. Müller;Vikas Kotagal;Robert A. Koeppe

  383
  Citations

• Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature

  Nicolaas I. Bohnen;David S.W. Djang;Karl Herholz;Yoshimi Anzai

  350
  Citations

• Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches

  Unknown

  309
  Citations

• Cholinergic Dysfunction in Parkinson’s Disease

  Martijn L. T. M. Müller;Nicolaas I. Bohnen

  301
  Citations

• Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease

  Nicolaas I Bohnen;Roger L Albin;Roger L Albin;Robert A Koeppe;Kristine A Wernette

  294
  Citations

• SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0

  David S.W. Djang;Marcel J.R. Janssen;Nicolaas Bohnen;Jan Booij

  286
  Citations

• Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism

  Richard K J Brown;Nicolaas I. Bohnen;Ka Kit Wong;Satoshi Minoshima

  281
  Citations

• Neuropsychological deficits in patients with persistent symptoms six months after mild head injury.

  N. Bohnen;J. Jolles;A. Twijnstra

  271
  Citations

• SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0

  Satoshi Minoshima;Alexander E. Drzezga;Henryk Barthel;Nicolaas Bohnen

  269
  Citations

• White matter lesions in Parkinson disease.

  Nicolaas I. Bohnen;Roger L. Albin

  262
  Citations

• Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease

  Vikas Kotagal;Roger L. Albin;Roger L. Albin;Martijn L. T. M. Müller;Robert A. Koeppe

  259
  Citations

• Gait speed in Parkinson disease correlates with cholinergic degeneration

  Nicolaas I. Bohnen;Kirk A. Frey;Kirk A. Frey;Stephanie Studenski;Vikas Kotagal

  252
  Citations

• Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study

  Nicolaas I. Bohnen;Robert A. Koeppe;Satoshi Minoshima;Bruno Giordani

  250
  Citations

• Neurobehavioral aspects of postconcussive symptoms after mild head injury

  N. Bohnen;J. Jolles

  220
  Citations

• Update on Appropriate Use Criteria for Amyloid PET Imaging: Dementia Experts, Mild Cognitive Impairment, and Education

  Keith A. Johnson;Satoshi Minoshima;Nicolaas I. Bohnen;Kevin J. Donohoe

  219
  Citations